Literature DB >> 16521278

Lipoteichoic acid (LTA) from Staphylococcus aureus stimulates human neutrophil cytokine release by a CD14-dependent, Toll-like-receptor-independent mechanism: Autocrine role of tumor necrosis factor-[alpha] in mediating LTA-induced interleukin-8 generation.

Katja Hattar1, Ulrich Grandel, Alexander Moeller, Ludger Fink, Julia Iglhaut, Thomas Hartung, Siegfried Morath, Werner Seeger, Friedrich Grimminger, Ulf Sibelius.   

Abstract

OBJECTIVE: In sepsis, Gram-positive and Gram-negative bacteria provoke similar inflammatory processes. Whereas lipopolysaccharides (LPSs) are acknowledged as the principal immunostimulatory components of Gram-negative bacteria, the effect of the Gram-positive cell wall component lipoteichoic acid (LTA) is less well characterized. In the present study, we investigated the effect of highly purified LTA from Staphylococcus aureus on cytokine generation by isolated human neutrophils.
SUBJECTS: Isolated human neutrophils from healthy volunteers.
INTERVENTIONS: Incubation of neutrophils with purified LTA from S. aureus in the absence or presence of interleukin (IL)-10, anti-CD14, or anti-Toll-like-receptor antibodies. MEASUREMENTS: Measurement of tumor necrosis factor (TNF)-alpha, IL-1beta, and IL-8 by enzyme-linked immunosorbent assay. Analysis of IL-8 mRNA by reverse transcriptase polymerase chain reaction.
CONCLUSIONS: The LTA challenge provoked a dramatic release of cytokines, with an early appearance of TNF-alpha and IL-1beta and a delayed liberation of IL-8. The first phase of IL-8 production was induced directly by LTA, whereas the second phase was endogenously mediated by TNF-alpha, as it was largely abrogated by neutralizing anti-TNF-alpha antibodies. In contrast, IL1-beta was not involved in LTA-induced IL-8 generation. Interestingly, the late phase of IL-8 generation could also be attenuated by exogenous IL-10, probably as a consequence of its downregulatory effects on TNF-alpha generation. When investigating the mechanism of LTA-induced cellular activation, activity-neutralizing antibodies demonstrated that CD14 was involved in LTA-mediated neutrophil cytokine generation. Using antibodies that neutralize the activity of Toll-like receptor 2 (TLR2) or 4 (TLR4), we also show that CD14-dependent, LTA-induced neutrophil activation did not proceed via TLR2- or TLR4-mediated pathways. In conclusion, LTA is a potent activator of human neutrophil cytokine generation, with the synthesis of the chemokine IL-8 being largely dependent on TNF-alpha generation in an autocrine fashion. This LTA-induced effect was inhibited by IL-10, dependent on CD14, and independent of TLR 2 or 4.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16521278     DOI: 10.1097/01.ccm.0000202204.01230.44

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  20 in total

Review 1.  Functional adaptations of the transcriptome to mastitis-causing pathogens: the mammary gland and beyond.

Authors:  Juan J Loor; Kasey M Moyes; Massimo Bionaz
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-10-04       Impact factor: 2.673

2.  Strain differences in alveolar neutrophil infiltration and macrophage phenotypes in an acute lung inflammation model.

Authors:  Yinzhong Zhang; Xinchun Lin; Kiyokazu Koga; Koichiro Takahashi; Helena M Linge; Adriana Mello; Teresina Laragione; Percio S Gulko; Edmund J Miller
Journal:  Mol Med       Date:  2011-04-28       Impact factor: 6.354

3.  Infected atopic dermatitis lesions contain pharmacologic amounts of lipoteichoic acid.

Authors:  Jeffrey B Travers; Amal Kozman; Nico Mousdicas; Chandan Saha; Megan Landis; Mohammed Al-Hassani; Weiguo Yao; Yongxue Yao; Ann-Marie Hyatt; Michael P Sheehan; Anita N Haggstrom; Mark H Kaplan
Journal:  J Allergy Clin Immunol       Date:  2009-12-04       Impact factor: 10.793

4.  Effects of the TLR2 agonists MALP-2 and Pam3Cys in isolated mouse lungs.

Authors:  Martina Barrenschee; Dennis Lex; Stefan Uhlig
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

5.  Both TLR2 and TLR4 are required for the effective immune response in Staphylococcus aureus-induced experimental murine brain abscess.

Authors:  Werner Stenzel; Sabine Soltek; Monica Sanchez-Ruiz; Shizuo Akira; Hrvoje Miletic; Dirk Schlüter; Martina Deckert
Journal:  Am J Pathol       Date:  2007-12-28       Impact factor: 4.307

6.  Nrf2 promotes alveolar mitochondrial biogenesis and resolution of lung injury in Staphylococcus aureus pneumonia in mice.

Authors:  Janhavi Athale; Allison Ulrich; Nancy Chou MacGarvey; Raquel R Bartz; Karen E Welty-Wolf; Hagir B Suliman; Claude A Piantadosi
Journal:  Free Radic Biol Med       Date:  2012-08-23       Impact factor: 7.376

7.  Diverse action of lipoteichoic acid and lipopolysaccharide on neuroinflammation, blood-brain barrier disruption, and anxiety in mice.

Authors:  Raphaela Mayerhofer; Esther E Fröhlich; Florian Reichmann; Aitak Farzi; Nora Kogelnik; Eleonore Fröhlich; Wolfgang Sattler; Peter Holzer
Journal:  Brain Behav Immun       Date:  2016-10-14       Impact factor: 7.217

8.  Mycobacteria attenuate nociceptive responses by formyl peptide receptor triggered opioid peptide release from neutrophils.

Authors:  Heike L Rittner; Dagmar Hackel; Philipp Voigt; Shaaban Mousa; Andrea Stolz; Dominika Labuz; Michael Schäfer; Michael Schaefer; Christoph Stein; Alexander Brack
Journal:  PLoS Pathog       Date:  2009-04-03       Impact factor: 6.823

9.  Bacillus anthracis peptidoglycan stimulates an inflammatory response in monocytes through the p38 mitogen-activated protein kinase pathway.

Authors:  Marybeth Langer; Alexander Malykhin; Kenichiro Maeda; Kaushik Chakrabarty; Kelly S Williamson; Christa L Feasley; Christopher M West; Jordan P Metcalf; K Mark Coggeshall
Journal:  PLoS One       Date:  2008-11-12       Impact factor: 3.240

Review 10.  Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review.

Authors:  Dinna N Cruz; Mark A Perazella; Rinaldo Bellomo; Massimo de Cal; Natalia Polanco; Valentina Corradi; Paolo Lentini; Federico Nalesso; Takuya Ueno; V Marco Ranieri; Claudio Ronco
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.